Stock TXTM PROTEXT MOBILITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

ProText Mobility, Inc. Stock Other OTC

Equities

TXTM

US74371E2046

Biotechnology & Medical Research

Chart ProText Mobility, Inc.

Dynamic Chart

Latest news about ProText Mobility, Inc.

Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update CI
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility CI
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc. CI
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc. CI
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc CI
Protext Mobility, Inc. to Conduct Human Clinical Trial with Its Product Phytofare Catechin Complex CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million. CI
Protext Mobility, Inc. Engages in the Development of Pharmaceutical Applications for the Highly Bioavailable Phytofare® CI
Plandai SA completed the acquisition of ProText Mobility, Inc. in a reverse merger transaction. CI
Plandai SA agreed to acquire ProText Mobility, Inc. in a reverse merger transaction. CI
More news

Press releases ProText Mobility, Inc.

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION AQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE EQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE AQ
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP AQ
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended PU
More press releases

Managers and Directors - ProText Mobility, Inc.

Managers TitleAgeSince
Plooy Du Dylon CEO
 Chief Executive Officer - -
Ahmed Jamaloodeen CHM
 Chairman - -
Members of the board TitleAgeSince
Ahmed Jamaloodeen CHM
 Chairman - -
Plooy Du Dylon CEO
 Chief Executive Officer - -
More insiders

Company Profile

Protext Mobility, Inc. is a biotech company, which is engaged in the development of a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. The Company is engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. The Company’s subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.
Sector
Biotechnology & Medical Research
More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-0.28% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.78% 96.73B
ARGENX SE Stock argenx SE
+1.66% 21.31B
BIONTECH SE Stock BioNTech SE
-16.18% 21.21B
GENMAB A/S Stock Genmab A/S
-6.82% 18.79B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.41% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-23.15% 13.68B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.63% 13.44B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+22.12% 10.98B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. TXTM Stock
  4. TXTM Stock